Polster, Annikka
Öhman, Lena
Tap, Julien
Derrien, Muriel
Le Nevé, Boris
Sundin, Johanna
Törnblom, Hans
Cvijovic, Marija
Simrén, Magnus
Funding for this research was provided by:
Seventh Framework Programme (607652)
Swedish Medical Research Council (02317, 02317, 13409, 21691)
University of Gothenburg
Article History
Received: 1 April 2020
Accepted: 15 February 2021
First Online: 9 March 2021
Competing interests
: AP: No competing interests JS: No competing interests JT: Employee of Danone Nutricia MD: Employee of Danone Nutricia BL: Employee of Danone Nutricia HT: served as Consultant/Advisory Board member for Almirall, Danone, and Shire LÖ: No competing interests MC: No competing interests MS: received unrestricted research grants from Danone, and Ferring Pharmaceuticals, and served as a Consultant/Advisory Board member for AstraZeneca, Danone, Nestlé, Almirall, Allergan, Albireo, Glycom, and Shire, and as a speaker for Tillotts, Menarini, Takeda, Shire, Allergan, and Almirall.